|Articles|January 10, 2017
Profil Institute Becomes ProSciento, Inc.
Profil Institute for Clinical Research, Inc. has announced the launch of its new corporate name, ProSciento Inc.
Advertisement
Profil Institute for Clinical Research, Inc. has announced the launch of its new corporate name, ProSciento Inc. Under a broader rebranding campaign, the name change represents the company’s focus on metabolism clinical R&D for diabetes, obesity and NAFLD/NASH.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
Everything to Know About FDA’s Push Towards Radical Transparency in 2025September 17th 2025
IQVIA and Veeva Join Forces to Improve Efficiency and Patient OutcomesSeptember 17th 2025
Managing Background Therapies in the NIMBLE Phase III TrialSeptember 17th 2025
Generative AI Transforms Clinical Study Report DevelopmentSeptember 16th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Everything to Know About FDA’s Push Towards Radical Transparency in 2025
2
Generative AI Transforms Clinical Study Report Development
3
Why Clinical Trials Are at a Crossroads and How Site Networks Are the Key to Success
4
IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
